The robust anti-tumor phenotype in Cav-2 KO mice is evidenced by the results obtained using two independent syngeneic models of tumor growth in immunocompetent mice involving subcutaneous implantation with LLC and CMT 167 lung carcinoma cell lines. The gene discussed is CAV2; the disease is lung carcinoma.